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PEDIATRIC UROLOGY
8DOUBLE-J STENT INSERTION ACROSS VESICOURETERAL
JUNCTION—IS IT A VALUABLE INITIAL APPROACH IN
NEONATES AND INFANTS WITH SEVERE PRIMARY
NONREFLUXING MEGAURETER?
MARCO CASTAGNETTI, MARCELLO CIMADOR, MARIA SERGIO, AND ENRICO DE GRAZIA
ABSTRACT
bjectives. To evaluate the role of double-J stent insertion in perinatally detected primary nonrefluxing
egaureters as a method to temporize treatment in patients with impaired renal function or to prevent
unction loss in patients treated expectantly, but deemed at high risk of deterioration.
ethods. Two neonates and 8 infants with a ureter greater than 10 mm and an obstructive excretion
attern, including 3 cases with renal function less than 40%, were selected to undergo double-J stent
nsertion for a 6-month period. Patients underwent surgery if the ureter redilated and the excretion pattern
as obstructive at reassessment 3 months after stent removal.
esults. Stents were placed at a median age of 3 months (range 1 to 6). Open insertion was necessary in
cases (50%). Seven patients (70%) developed stent-related complications (five breakthrough urinary
nfections) requiring early stent removal in 2 (20%). Five patients (50%) underwent surgery at a median age
f 14 months (range 13 to 27), including the 3 patients with decreased renal function at presentation. None
equired ureteral tapering. None experienced any renal function loss with respect to the initial evaluation.
onclusions. Double-J stent insertion across the vesicoureteral junction allows for effective internal drain-
ge of primary nonrefluxing megaureters, but at the cost of a 70% morbidity rate and various technical
rawbacks. Therefore, stenting should be considered on a case-by-case basis. The procedure seems
aluable to temporize surgery in patients with decreased renal function. However, given the associated
orbidity, it seems impractical for patients with preserved function selected in accordance with currently
vailable prognostic indicators. UROLOGY 68: 870–876, 2006. © 2006 Elsevier Inc.t
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about 80% of perinatally detected primary non-
refluxing megaureters (PNRMs) resolve sponta-
eously; hence, conservative management is gen-
rally considered a safe initial approach.1,2 Initial
anagement, however, can be a clinical dilemma
hen treating neonates and infants with a PNRM
ssociated with impaired renal function. In these
ases, diversion can be considered appropriate to
ostpone definitive treatment until after 1 year of
ge and/or allow accurate assessment of renal func-
ion before embarking on major bladder recon-
truction.3–5
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70 ALL RIGHTS RESERVEDExternal urinary diversion is a well-established
emporizingmeasure in children with urinary tract
bstruction. However, both nephrostomy tubes and
utaneous ureterostomy have their limitations, and
ethods for internal drainage would be prefera-
le.3,4 Lee et al.5 have recently suggested creation of
refluxing reimplantation as an internal diversion
ethod according to the principle that surgery can
e safely deferred if vesicoureteral junction (VUJ)
bstruction is exchanged for the less harmful vesi-
oureteral reflux (VUR).5 Double-J stent insertion
cross the VUJ is potentially a minimally invasive
lternative to achieve temporary internal drainage
f PNRMs.
In addition, we thought that this procedure,
eing reversible, could also serve in patients
ith PNRM with preserved function but deemed
t high risk of deterioration. We hypothesized
hat the stent could be beneficial in three ways:
0090-4295/06/$32.00
doi:10.1016/j.urology.2006.05.052
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Uy ensuring unimpaired flow across the VUJ
hile waiting for spontaneous maturation of the
unction; by stretching the stenotic ureteral seg-
ent; and/or by decompressing the system and
hus making subsequent assessment of the uri-
ary excretion pattern reliable.
We report our experience with double-J stent
nsertion in neonates and infants with PNRMs and
ither impaired or preserved function.
MATERIAL AND METHODS
In the period 2000 to 2004, 2 neonates and 8 infants (6 boys
nd 4 girls) having an asymptomatic PNRM underwent dou-
le-J stent insertion across the VUJ at our institution. The
NRM was on the left side in 6 cases, the right in 3, and
ilateral in 1, accounting for a total of 11 affected renoureteral
nits.
The criteria for stent insertion were either a differential
enal function on the affected side of less than 40% (n 3) or
he presence of prognostic indicators suggesting a significant
isk of renal function deterioration (n 7), namely a diameter
f the retrovesical ureter greater than 10 mm associated with a
learly obstructive excretion pattern.6
The evaluation before stent insertion included renal ultra-
ound scans, cyclingmicturating cystouretrography (MCUG),
nd 3-mercaptoacetylglycine scintigraphy with diuretic renogra-
hy (n 9) or diuretic intravenous urography (n 1).
On ultrasound scan, the cross-section diameter of the
etrovesical ureter and anteroposterior diameter of the re-
al pelvis on a transverse plane were determined.
Diuretic tests were performed with an indwelling cathe-
er. On diuretic renography, obstruction was defined as a
alf-life of the isotope greater than 20 minutes after diuretic
njection (furosemide 1 mg/kg). On intravenous urography,
t was defined as the persistence of contrast in the renal
elvis for longer than 20 minutes after diuretic administra-
ion, with diuretic being injected after complete emptying
f the nondilated renoureteral unit.
Prophylactic antibiotics were administered to all the pa-
ients.
The ureteral stents used were 3F, 12-cm-long, polyurethane
ouble-J stents without valves (Rusch International, Kernen,
ermany). Such stents are provided with a guidewire and a 5F
usher and can be inserted transuretherally using a 10F cys-
oscope. The maximal period of stenting recommended by the
anufacturer is 6 months.
Cystoscopic insertion was always attempted. If it failed, the
tent was inserted by way of a minimal cystostomy, in which
ase dilation of the ureteral meatus was also done. Dilation
as started with a lachrymal probe and continued with ure-
eral catheters up to 5F.
No effort was made to reach the renal pelvis with the stent.
During stenting, children were followed up with monthly
rine tests and ultrasound scans. No dimercaptosuccinic acid
can was performed after urinary tract infection.
The stents were removed after 6 months, or earlier if clini-
ally indicated. The removal was always done endoscopically.
complete reassessment was performed 3 months after stent
emoval.
Patients underwent ureteral reimplantation if, at reassessment,
he differential function of the affected kidney was less than 40%
r if anobstructed excretionpatternwas foundondiuretic testing
ssociated with progressive redilation of the ureter.
Ureteral tapering was performed only if, after resection of
he stenotic segment, the width of the collapsed ureter at in-
raoperative assessment was greater than 10 mm and/or the a
ROLOGY 68 (4), 2006ladder was not wide enough to accommodate a submucosal
unnel five times longer than the ureteral width.
All patients who underwent surgery underwent follow-up
CUG 6 months after surgery. The patients who did not un-
ergo surgery were followed up with periodic assessments.
he median follow-up period after removal was 19 months
range 8 to 36).
RESULTS
The results are summarized in Figure 1. Before
tent placement, the median ureteral diameter
as 15 mm (range 11 to 19), and the median
nteroposterior pelvic diameter was 36 mm
range 29 to 43). The excretion pattern was ob-
tructive in all the patients, and 3 patients pre-
ented with a differential function of less than
0% (range 29% to 34%). The median patient age
t stent insertion was 3 months (range 1 to 6).
Open insertion was required in 5 cases (50%), 1
ilateral case because of the impossibility to fit the
ystoscope into the urethra (n  2) or to pass the
tent through the ureteral meatus (n  3).
All ureters decreased in size during stenting, as
hown by the ultrasound scans (Fig. 2).
Stent-related complications developed in 7 pa-
ients (70%), including breakthrough infections
n 5, blockage due to intracorporeal knotting of
he stent in 1, and chronic hematuria in 1. Break-
hrough infections were febrile in 2 cases. Early
tent removal was required in 2 cases (20%), 1
ith a fungal renal infection unresponsive to
edical treatment and 1 in the child with the
locked stent.
All the stents were successfully removed cysto-
copically; four presentedwith encrustations local-
zed to the tips.
At reassessment 3 months after stent removal,
e novo VUR was detected in 3 of 10 patients.
his, however, was no longer present on fol-
ow-up MCUG performed after an additional 6
onths.
In the 3 patients with impaired function at pre-
entation, ureteral dilation recurred and the excre-
ion pattern was obstructive. The differential renal
unction persisted unchanged in all 3 patients at
ess than 40%.
Of the 7 patients with preserved function at
resentation, the dilation did not recur in 5 (n
, Fig. 2) or was very mild (n  2, 3 and 4 mm),
nd the excretion pattern became unobstructive.
n the remaining 2, the ureter redilated (8 and 9
m), and the excretion pattern was persistently
bstructive. The differential renal function per-
isted unchanged at greater than 40% in all 7
atients.
Five patients (50%), all with unilateral PNRM,
nderwent ureteral reimplantation at a median
ge of 14 months (range 13 to 27). These in-
871
c
t
T
r
e
p
o
s
c
P
A
M
d
o
A
(
r
i
r
r
n
o
t
t
p
s
p
w
o
s
m
P
i
u
l
c
m
a
7
b
s
h
a
P
b
n
c
F
d tic in
8luded the 3 patients with decreased renal func-
ion at presentation and 2 with normal function.
he latter underwent surgery because of recur-
ent ureteral dilation and the persistent obstructive
xcretion pattern after stent removal.
Two of the 5 patients requiring open stent
lacement underwent surgery; the previous
pen stent placement did not interfere with sub-
equent reimplantation. The latter was done ac-
ording to Cohen in 3 patients and according to
olitano in 2. None required ureteral tapering.
ll patients did well after surgery, and follow-up
CUG did not show any VUR.
Five patients (50%), one with bilateral PNRM,
id not undergo ureteral reimplantation. Three
f these had undergone open stent placement.
fter a median follow-up after removal of 24months
range 11 to 36), all were asymptomatic. The ret-
ovesical ureter was not visible in 3 cases, includ-
ng the bilateral case, and was 3 and 5 mm in the
emaining 2. The anteroposterior diameter of the
enal pelvis was less than 20 mm in three re-
oureteral units and between 20 and 30 mm in the
ther three. All patients presented with a differen-
ial renal function of the affected kidney greater
han 40% and an unobstructed urinary excretion
IGURE 1. Results of stent placement in 10 patients i
efined by half-life greater than 20 minutes after diureattern on diuretic renography. c
72COMMENT
We described our experience with double-J
tent insertion across the VUJ as an initial ap-
roach in asymptomatic neonates and infants
ith PNRM. This represents the second report
n this approach previously described in 2
ymptomatic infants.7
The procedure proved to be an effective
ethod of achieving internal drainage of
NRMs, because all megaureters decreased dur-
ng stenting. Moreover, none of the 5 patients
ndergoing reimplantation required ureteral tai-
oring, although ureteral tapering is generally
onsidered necessary in most reimplanted
egaureters.1,6,8 Double-J stenting, however,
lso proved to be associated with a concerning
0% morbidity rate and several technical draw-
acks such as the need for two anesthesia ses-
ions in all patients and for open insertion in one
alf the cases. Improvements could probably be
chieved by appropriate technical refinements.
rogressively smaller operative cystoscopes are
ecoming available, potentially reducing the
eed for open insertion in patients with a small
aliber urethra; stents provided with valves
esent series. RF  renal function. Obstructive pattern
jection (Lasix 1 mg/kg).n prould minimize the risk of infections.9 Also,
UROLOGY 68 (4), 2006
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Uagnetic retrieval of the stent could allow elim-
nating one anesthesia session.10 Nevertheless,
rawbacks and complications make the cost/
enefit ratio of the procedure questionable, and
he selection criteria for stenting become criti-
IGURE 2. Modifications in hydronephrosis (a,c,e) and
esolution. At presentation, (a) severe dilation of ren
ross-section diameter greater than 10 mm. After 6 mo
reter completely decompressed. Stent visible within bla
nly mild residual hydronephrosis persisted, with (f) recal. We performed VUJ stenting in two different
ROLOGY 68 (4), 2006ubsets of patients, in 3 patients already commit-
ed to surgery at presentation because of de-
reased renal function and in 7 with preserved
unction but deemed at high risk of deteriora-
ion.
eral dilation (b,d,f) on ultrasound scans in patients with
elvis visible, associated with (b) right ureter having
of stenting, (c) hydronephrosis had improved and (d)
(gray arrow). Finally, 3 months after stent removal, (e)
nt ureteral dilation no longer evident.uret
al p
nths
dderIn the former group, we sought to temporize
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8efinitive treatment using the procedure. The
eed to temporize bladder surgery before 1 year
f age because of the fear of jeopardizing bladder
ehavior has been greatly questioned in recent
ears.11,12 Temporization, however, can still be re-
uired in selected patients presenting with urinary
nfections unresponsive to medical treatment, or in
hose with significant renal impairment, to allow
ccurate assessment of renal function and evaluate
he potential for recovery before embarking onma-
or bladder reconstruction. Temporization has
lassically been achieved by external urinary diver-
ion by way of nephrostomy tubes or cutaneous ure-
erostomy.3,4 Both methods, however, are cumber-
ome, prone to complications, difficult to handle,
nd not well accepted by parents. Internal drainage
s theoretically a better option. One method to
chieve internal drainage in megaureters is endo-
copic incision of the narrowed ureteral segment.13
ee et al.5 have recently attempted creation of a
efluxing ureteral reimplantation as a temporizing
easure in 3 infants with a severe PNRM and sig-
ificant function deterioration. Both procedures
ork by exchanging VUJ obstruction for the less
armful VUR and unavoidably commit the child to
econdary bladder reconstruction. Moreover, 1 of
he patients in the series by Lee et al.5 ended up
ndergoing nephrectomy; therefore, in this pa-
ient, a refluxing stump was left behind, which
ould have been avoided with a stent.
Double-J stent insertion across the VUJ allows,
t least in hortotopic PNRMs, the establishment of
eversible internal drainage in a minimally inva-
ive manner. A possible disadvantage could be that,
ith the currently available devices, stenting can-
ot be prolonged beyond 6months unless the stent
s changed. However, we postponed surgery in our
atients for an additional 3 months after stent
emoval, reaching a median age at surgery of 14
onths. This did not cause function loss or result
n the need for ureteral tapering at reimplantation
n any of our patients. The effect of the stent on the
UJ seemed to persist for a period after removal, as
uggested by the appearance of transitory reflux in
patients.
We also attempted double-J stent insertion in
atients with preserved renal function but
eemed at high risk of deterioration. In keeping
ith the findings of Liu et al.,6 the predictors of
unction deterioration were a retrovesical ureter
reater than 10 mm and a severely obstructive
xcretion pattern on diuretic testing.6 The major
roblem in patients with massive hydronephro-
is is that the dilation dramatically increases the
ompliance of the system.14 This, in turn, can
ause the isotope to quickly dilute within the
ystem after diuretic injection, mimicking an ob-
tructive excretion pattern even in the absence of p
74rue VUJ obstruction.15 In this scenario, there-
ore, the clinician cannot rely on the presence of
n obstructive excretion curve to select patients
or surgery and is, instead, forced to wait for
enal function deterioration. We hypothesized
hat stenting could be beneficial in these patients
n three ways: First, by ensuring unimpaired uri-
ary drainage while waiting for spontaneous
aturation of the VUJ. Second, the stent would
iden by stretching (in combination with dila-
ion in the patients undergoing open placement)
he stenotic distal ureter. Finally, stenting would
ecompress the system, and thus restore the
onditions of normal excretion physiology and
llow reliable assessment of the excretion pat-
ern. None of our patients developed any renal
amage while stented. Also, at reassessment 3
onths after removal, we observed two different
esponse patterns to stenting. In 5 patients, the
ilation did not recur and the excretion pattern
ecame unobstructive, and in the other 2, the
reter redilated and the excretion pattern per-
isted as obstructive. The latter was the same
ehavior of the PNRMs in the patients with de-
reased renal function. In the absence of a con-
rol group, it was not possible to use our data to
raw any definitive conclusion on the effect of
he stent on the VUJ. In the 5 patients with res-
lution, the improvement could have been a re-
ult of the natural history of the disease. For the
patients with recurrence, it remains unproved
hat any renal function loss would have occurred
ith observational management. Consistent
ith the rationale of our approach, however, it
eemed unethical to continue conservative treat-
ent for the latter 2 patients.
Nevertheless, the major concern with this ap-
roach is not the incomplete evidence of its effec-
iveness, but rather the associated morbidity. Pre-
equisite todetermining the role of double-J stenting,
f any, in the treatment of neonates and infants
ith PNRMs and preserved function is the pres-
nce of strict criteria to select patients with a risk of
enal function deterioration that would outweigh
he morbidity of stenting. Overwhelming evidence
as suggested that conservative management is a
afe initial option for almost all patients with PN-
Ms and preserved function. Even in those with
he features suggested by Liu et al.,6 conservative
anagementwould have been harmless in asmuch
s 75%. Our review of published reports, however,
ailed to identify better selection criteria. Of the
rognostic indicators investigated in addition to
hose we used, patient gender and the laterality of
he PNRM failed to show any prognostic value.2 In
ontrast, the degree of associated hydronephrosis
roved to be a good predictor of the time to reso-
UROLOGY 68 (4), 2006
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Uution of the megaureter, but not of the risk of
unction deterioration.2
CONCLUSIONS
Double-J stent insertion across the VUJ allows
ffective internal drainage of PNRMs. Moreover,
one of the stented PNRMs needing reimplanta-
ion required tapering. The procedure, however,
s associated with a 70% morbidity rate and sev-
ral technical drawbacks, including the need for
wo anesthesia session in all the patients and for
pen stent insertion in one half of cases. There-
ore, the cost / benefit ratio should be evaluated
n a case-by-case basis. It seems that double-J
tenting can be considered one of the options
hen temporization is required in selected pa-
ients with hortotopic PNRM and decreased re-
al function. Using currently available prognos-
ic indicators, none of the patients with PNRMand
reserved function seemed to be at risk of deterio-
ation that would have outweighed the morbidity
f the procedure.
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EDITORIAL COMMENT
Routine use of prenatal ultrasound scans results in an in-
reased frequency of urologists evaluating asymptomatic in-
ants with hydroureteronephrosis. Management alternatives
nclude observation with serial ultrasound scans and/or nu-
lear renal scans, cutaneous ureterostomy, ureteral reimplan-
ation, and ureteral stenting. Although ureteral stenting is a
ommon technique for bypassing ureteral obstruction in older
atients, reports of its use in the setting of a primary obstruc-
ive megaureter (POM) are limited.1
The authors describe placement of a double-J stent in 10
hildren with asymptomatic POMs. They are to be congrat-
lated on a critical review of their results. They noted a
omplication rate of 70% with this technique, including
reakthrough infections in 50%. In addition, 5 patients
50%) required open insertion of the stent. In 2 of these
atients, the 10F cystoscope was too large for the urethra.
he use of a smaller scope might have resulted in a lower
ate of open insertions. Three months after removal of the
reteral stent, all patients underwent repeat renal scan. The
ndications for ureteral reimplantation in 5 patients con-
isted of a differential renal function of less than 40% or an
bstructed excretion pattern associated with progressive
edilation of the ureter.
From the authors’ results, it remains difficult to deter-
ine in which patients ureteral stenting should be used.
even patients had relative renal function greater than 40%
nd many would have continued to follow-up these patients
ithout immediate intervention. The 3 patients with rela-
ive function less than 40% underwent subsequent ureteral
eimplantation. The authors noted that no patient required
tapered ureteral reimplant; however, whether this re-
ulted from stent placement or was simply a consequence of
he natural history of megaureters to improve with time
ould not be determined from this study.2 If proven with
dditional studies, the ability of stenting to decrease the
eed for tapered ureteral reimplantation could ultimately
ecrease the complications of persistent reflux or obstruc-
ion associated with these reimplants.3
Given the high complication rate and the need for multiple
perations, the authors’ conclusion that the use of ureteral
tenting should be limited to very select patients seems valid.
ne potential setting for this technique may be its use in
quivocal cases in which renal function significantly improves
fter stent insertion and then worsens after stent removal,
onfirming obstruction and the need for definitive surgical
ntervention. This may occur in the setting of bilateral POMs
r a solitary kidney with a POM. However, the potential to
ecrease the need for ureteral tapering must be evaluated fur-
her and weighed against the same potential with other forms
f POM management.
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